Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard G Frank

Showing results (11-20 of 165) with videos related to

Pageof 17
Sort By:
The American Journal of Psychiatry|December 6, 2013
Helping (some) SSDI beneficiaries with severe mental illness return to workRichard G Frank
Psychiatric Services (Washington, D.C.)|June 24, 2026
Medicaid Reforms in the One Big Beautiful Bill Act and Mental Health CareRichard G Frank
Health Affairs (Project Hope)|May 22, 2003
Government commitment and regulation of prescription drugsRichard G Frank
The New England Journal of Medicine|November 16, 2007
The ongoing regulation of generic drugsRichard G Frank
The New England Journal of Medicine|September 1, 2007
Regulation of follow-on biologicsRichard G Frank
Journal of Health Economics|February 28, 2003
New estimates of drug development costsRichard G Frank
The New England Journal of Medicine|October 15, 2011
Medicare drug prices and the deficitRichard G Frank
The New England Journal of Medicine|October 2, 2004
Prescription-drug pricesRichard G Frank
JAMA Health Forum|July 14, 2023
Drug Development-Social and Private ReturnsRichard G Frank
Psychiatric Services (Washington, D.C.)|May 3, 2008
Policy toward second-generation antipsychotic drugs: a cautionary noteRichard G Frank
Pageof 17

Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
The American Journal of Psychiatry|December 6, 2013
Helping (some) SSDI beneficiaries with severe mental illness return to workRichard G Frank
Psychiatric Services (Washington, D.C.)|June 24, 2026
Medicaid Reforms in the One Big Beautiful Bill Act and Mental Health CareRichard G Frank
Health Affairs (Project Hope)|May 22, 2003
Government commitment and regulation of prescription drugsRichard G Frank
The New England Journal of Medicine|November 16, 2007
The ongoing regulation of generic drugsRichard G Frank
The New England Journal of Medicine|September 1, 2007
Regulation of follow-on biologicsRichard G Frank
Journal of Health Economics|February 28, 2003
New estimates of drug development costsRichard G Frank
The New England Journal of Medicine|October 15, 2011
Medicare drug prices and the deficitRichard G Frank
The New England Journal of Medicine|October 2, 2004
Prescription-drug pricesRichard G Frank
JAMA Health Forum|July 14, 2023
Drug Development-Social and Private ReturnsRichard G Frank
Psychiatric Services (Washington, D.C.)|May 3, 2008
Policy toward second-generation antipsychotic drugs: a cautionary noteRichard G Frank
Pageof 17